262
Participants
Start Date
September 8, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
December 31, 2027
Saline (0.9%, sterile, for infusion)
Sailine as control
low dose Methylprednisolone
Methylprednisolone 0.5mg/kg ivgtt qd
Moderate dose Methylprednisolone
Methylprednisolone 1.0mg/kg ivgtt qd
Qingyuan Zhan
OTHER